Evidence map›Paper›PMID 35118088›Full record

ArticleFrontiers in medicine2021

Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature.

Vito Fiore, Rosalba Beretta, Andrea De Vito, Aleksandra Barac, Ivana Maida, David David Joeseph Kelvin, Claudia Piu, Vincenzo Lai, Giordano Madeddu, Salvatore Rubino and 3 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. The role of CaCell calcium · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Vito FioreUnit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Rosalba BerettaDepartment of Emergency, Area Socio-Sanitaria Locale, Olbia, Italy.
Andrea De VitoUnit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Aleksandra BaracFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Ivana MaidaUnit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
David David Joeseph KelvinDepartment of Microbiology and Immunology, Faculty of Medicine, Canadian Center for Vaccinology, Dalhousie University, Halifax, NS, Canada.
Claudia PiuUnit of Microbiology and Virology, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy.
Vincenzo LaiUnit of Microbiology and Virology, Azienda Ospedaliero-Universitaria di Sassari, Sassari, Italy.
Giordano MadedduUnit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Salvatore RubinoFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Goran StevanovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Stefan KoricaFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Sergio BabudieriUnit of Infectious Diseases, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
University of Sassari · ITUniversity of Belgrade · RSASL Roma · ITAzienda Ospedaliero Universitaria di Sassari · ITShantou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSARS-CoV-2 is fundamentally a respiratory pathogen with a wide spectrum of symptoms. The COVID-19 related pancreatitis is less considered than other clinical features. The purpose is to describe two cases of pancreatitis associated with COVID-19. METHODOLOGY: Patients' demographics, clinical features, laboratory, and instrumental findings were collected.

resultsTwo patients admitted to the hospital were diagnosed with COVID-19 and severe acute pancreatitis, according to the Atlanta criteria. Other causes of acute pancreatitis were excluded. Treatment included broad-spectrum antibiotics, proton pump inhibitors, and low molecular weight heparin. Steroids, oxygen, antifungal treatment, and pain killers were administered when appropriate. Both patients were asymptomatic, with normal vital parameters and blood exams, and were discharged in a good condition.

conclusionIt is recommendable to include lipase and amylase on laboratory routine tests in order to evaluate the need for the abdominal CT-scan and specific therapy before hospital admission of the patients with COVID-19 related life-threatening acute pancreatitis.

Indexed as

acuteangiotensin-converting enzymeCOVID-19SARS-CoV-2severe pancreatitis

Identifiers

PMID35118088
PMCPMC8804495
OpenAlexW4205887703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.